InvestorsHub Logo

Amatuer17

07/26/16 7:32 AM

#5126 RE: tonecee #5125

One key point - expected primary end point (which comes 2 weeks after last patient enrollment) will be sometime in 2017 - does not say H1 or H2.

The secondary end point - 6 months after that. 2-3 after that detailed data and apply for approval

So the approval will be in 2018

A BO after come after primary endpoint positive results

tonecee

07/26/16 7:34 AM

#5127 RE: tonecee #5125

First Patient Enrolled Under Newly Modified Protocol in CytoDyn’s Phase 3 PRO 140 Combination Study in HIV.

Revised protocol features a 50% reduction in the number of patients and relaxed enrollment criteria


http://content.equisolve.net/cytodyn/news/2016-07-26_First_Patient_Enrolled_Under_Newly_Modified_239.pdf